Abstract
Abstract
Background
This study aims to assess the effectiveness of OM-85 BV in treating recurrent acute tonsillitis in children and adults during the first year after treatment, as well as to identify response predictors.
Results
The study included 92 patients, and there was a significant decrease in the number of acute tonsillitis cases after OM-85 BV treatment (p < 0.001). Exposure to tobacco smoke predicts non-response or partial response to treatment (OR 5.24, p = 0.005, 95% CI 1.646–16.671/OR 4.57, p = 0.014, 95% CI 1.362–15.339).
Conclusions
The study concludes that OM-85 BV is effective in preventing new episodes of tonsillitis in patients with a history of recurrent acute tonsillitis. Patients exposed to tobacco smoke tend to have a poorer response to treatment.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Kaplan EL, Top FH Jr, Dudding BA, Wannamaker LW (1971) Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 123(5):490–501
2. Komaroff AL, Pass TM, Aronson MD, Ervin CT, Cretin S, Winickoff RN et al (1986) The prediction of streptococcal pharyngitis in adults. J Gen Intern Med 1(1):1–7
3. Schroeder BM (2003) Diagnosis and management of group A streptococcal pharyngitis. Am Fam Physician. 67(4):880–884
4. Mitchell RB, Archer SM, Ishman SL, Rosenfeld RM, Coles S, Finestone SA et al (2019) Clinical practice guideline: tonsillectomy in children (update). Otolaryngol Head Neck Surg. 160(1_suppl):S1–S42
5. Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ et al (2011) Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg 144(1 Suppl):S1-30